HealthStream (NASDAQ:HSTM) EVP Kevin O’hara Sells 2,000 Shares of Stock

HealthStream, Inc. (NASDAQ:HSTM) EVP Kevin O’hara sold 2,000 shares of the firm’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $24.26, for a total transaction of $48,520.00. Following the transaction, the executive vice president directly owned 16,373 shares of the company’s stock, valued at $397,208.98. The trade was a 10.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

HealthStream Stock Down 0.9%

Shares of HSTM stock opened at $24.05 on Tuesday. The company’s fifty day simple moving average is $25.62 and its two-hundred day simple moving average is $26.87. HealthStream, Inc. has a 52 week low of $23.91 and a 52 week high of $34.24. The stock has a market cap of $713.56 million, a P/E ratio of 35.37, a PEG ratio of 2.95 and a beta of 0.45.

HealthStream (NASDAQ:HSTM) last issued its earnings results on Monday, November 3rd. The technology company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.03. The firm had revenue of $76.47 million for the quarter, compared to analysts’ expectations of $75.52 million. HealthStream had a return on equity of 5.82% and a net margin of 6.93%. On average, analysts anticipate that HealthStream, Inc. will post 0.63 EPS for the current fiscal year.

HealthStream Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Shareholders of record on Monday, November 17th were paid a $0.031 dividend. The ex-dividend date of this dividend was Monday, November 17th. This represents a $0.12 dividend on an annualized basis and a yield of 0.5%. HealthStream’s payout ratio is presently 17.65%.

HealthStream announced that its Board of Directors has initiated a stock buyback program on Tuesday, November 11th that permits the company to buyback $10.00 million in outstanding shares. This buyback authorization permits the technology company to purchase up to 1.3% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its shares are undervalued.

Institutional Trading of HealthStream

Several hedge funds and other institutional investors have recently bought and sold shares of HSTM. Robeco Institutional Asset Management B.V. boosted its stake in HealthStream by 162.1% during the second quarter. Robeco Institutional Asset Management B.V. now owns 380,604 shares of the technology company’s stock worth $10,531,000 after buying an additional 235,382 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of HealthStream by 302.0% in the 2nd quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company’s stock worth $6,860,000 after acquiring an additional 186,231 shares during the last quarter. Copeland Capital Management LLC boosted its stake in shares of HealthStream by 15.6% during the 2nd quarter. Copeland Capital Management LLC now owns 882,950 shares of the technology company’s stock worth $24,431,000 after purchasing an additional 119,260 shares during the period. Qube Research & Technologies Ltd grew its holdings in HealthStream by 77.3% during the 2nd quarter. Qube Research & Technologies Ltd now owns 251,953 shares of the technology company’s stock valued at $6,972,000 after purchasing an additional 109,883 shares during the last quarter. Finally, Bridgeway Capital Management LLC purchased a new stake in HealthStream in the 1st quarter worth about $3,228,000. Hedge funds and other institutional investors own 69.58% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on HSTM. Weiss Ratings reissued a “hold (c)” rating on shares of HealthStream in a report on Wednesday, October 8th. Wall Street Zen lowered shares of HealthStream from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, HealthStream has a consensus rating of “Hold” and an average target price of $28.00.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.